The main aim of this study was to explore the immunoexpression of stem cell markers nestin, CD138 (syndecan-1), and alpha-SMA in a series of four cases of ameloblastic carcinoma and to compare this data to an ameloblastoma immunoexpression profile. The gene discussed is SDC1; the disease is ameloblastic carcinoma.